Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00038610
Status:
COMPLETED
Last Update Posted:
2015-09-18
First Post:
2002-06-03
Brief Title:
Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
Keywords:
| Name | View |
|---|---|
| Neupogen | View |
| Leukemia | View |
| Lymphoblastic | View |
| Acute | View |
| Philadelphia-Positive | View |
| Imatinib Mesylate | View |
| Gleevec | View |
| Glivec | View |
| Imatinib | View |
| STI571 | View |
| STI-571 | View |
| CGP-57148B | View |
| NSC-716051 | View |
| Cyclophosphamide | View |
| Cytoxan | View |
| Neosar | View |
| Doxorubicin | View |
| Adriamycin | View |
| Rubex | View |
| Adriamycin PFS | View |
| Adriamycin RDF | View |
| Vincristine | View |
| Dexamethasone | View |
| Decadron | View |
| Methotrexate | View |
| Cytarabine | View |
| Ara-C | View |
| Cytosar | View |
| DepoCyt | View |
| Cytosine Arabinosine Hydrochloride | View |
| Mesna | View |
| Mesnex | View |
| G-CSF | View |
| Filgrastim | View |